Aktuelle Studien

ProstataTherapieform
1st,2nd,3rd -line
Rekrutierung
PRIAS Prostate Cancer Research International – active surveillanceoffen
FIRSTANA Randomizes, open label, Multi-Center Study comparing Cabazitaxel at 25mg/m² and at 20mg/m²in Combination in with Prednisone everry 3 weeks  to Docetaxel in Combination with Prednisone in Patients with metastatic Castration Resistant Prostate Cancer not Pretreated with Chemotherapy Studiencode: EFC117842nd lineInitiierung  am 29.11.11
PROSELICA Randomizes, open label, Multi-Center Study comparing Cabazitaxel at 25mg/m² and at 20mg/m²in Combination in with Prednisone everry 3 weeks  to Docetaxel in Combination with Prednisone in Patients with metastatic Castration Resistant Prostate Cancer previously treated withe a docetaxel containing Regimen Studiencode: EFC117853rd lineInitiierung  am 29.11.11
Katheterstudie Randomisierte Studie zum Vergleich einer suprapubischen versus einer transurethralen Harnableitung nach konventioneller/roboterassistierter endoskopischer extraperitonealer radikaler Prostatektomie (EERPE/RALP)In Vorbereitung
SEAL extended vs. limited Lympahdenektomie beim Prostata-Ca

in Vorbereitung

Initiierung  ca. Nov / 11

MediathekInformation und Wissen
LageplanSo finden Sie uns